Filana Therapeutics (FLNA) Interest & Investment Income (2011 - 2023)

Filana Therapeutics' Interest & Investment Income history runs 13 years deep, the most recent figure standing at $2.2 million for Q2 2023.

• In Q2 2023, Interest & Investment Income rose 600.0% year-over-year to $2.2 million; the TTM figure through Jun 2023 stood at $6.7 million (up 1686.36% YoY), while the FY2022 annual figure was $2.8 million, up 5567.35% from the prior year.
• Interest & Investment Income for Q2 2023 stood at $2.2 million, up from $2.1 million in the prior quarter.
• The five-year high for Interest & Investment Income was $2.2 million in Q2 2023, with the low at $6000.0 in Q4 2020.
• The 5-year median for Interest & Investment Income is $66000.0 (2019), against an average of $417500.0.
• The sharpest annual moves came in 2020 and 2022: Interest & Investment Income sank 91.46% in 2020, then surged 11000.0% in 2022.
• Filana Therapeutics' Interest & Investment Income stood at $60000.0 in 2019, then sank by 90.0% to $6000.0 in 2020, then soared by 133.33% to $14000.0 in 2021, then soared by 11000.0% to $1.6 million in 2022, then jumped by 41.44% to $2.2 million in 2023.
• Business Quant data shows FLNA's Interest & Investment Income at $2.2 million in Q2 2023, $2.1 million in Q1 2023, and $1.6 million in Q4 2022.